Delisting riskPopularity #4,220
MREO · NASDAQ · Biotechnology

Mereo BioPharma Group (ADR) (MREO)

Advances acquired rare-disease drug candidates through clinical development and partnerships.

$0.3491
vs last close+0.03 (+10.37%)